DNDN - Dendreon Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DNDN - Dendreon Corp.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (699)	8/3/2011 4:41:05 PM
From: Arthur Radley	1 Recommendation Read Replies (3) of 751

In post #699 I stated that DNDN would have issues with reimbursement---finally today they admitted this was the issue for Q revenue numbers. "But what can only be described as a shocking turn of events, Dendreon confessed Wednesday that reimbursement concerns and issues are dragging on Provenge sales. A third Provenge manufacturing facility is under construction with FDA approval expected on August 28." Biotech CEO's can paint pretty pictures until finally the truth comes out! So now DNDN is firing employees and a new plant is being built!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next